iShares Biotechnology ETF (IBB)
$137.04
0.82 (0.59%)
IBB Stock Quote Delayed 30 Minutes
5 Top Stock Trades for Friday Morning
We saw another strong rally on Thursday in the broader U.S. stock market. That's got us eyeing a few new top stock trades for Friday.
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
-
PE Ratio
-
EPS
-
Volume (Avg. Vol.)
649,273
Day's Range
$136.60 - $138.80
52-Week Range
$123.96 - $150.57
Dividend & Yield
$0.40 (0.29%)
IBB Stock Predictions, Articles, and iShares Biotechnology ETF News
Trade of the Day: Celgene Corporation Is a Catch-Up Play
CELG stock continues to notably lag some of its peers in the biotechnology group, but this could soon change and set up a juicy Celgene trade.
Why Now Is the Perfect Time to Short Juno Therapeutics Inc Stock
A 50% pop on speculation is as good a reason to short JUNO stock as any. This is how you should play Juno Therapeutics now.
Trade of the Day: iShares NASDAQ Biotechnology Index (ETF) (IBB)
We will start to see whether investor optimism has been converted into sales this earnings season, which will get into full swing in the next few weeks. In the meantime, I'm looking to trade one of my favorite bullish themes: biotech.
Bet on Biogen Inc for Easy Profits Into the New Year
Biotech stocks are scary when they are falling. Sell downside risk into BIIB stock support with confidence for a chance at free profits.
Trade of the Day: Celgene Corporation Attempts a Breakout
CELG stock for the first time in a couple of months is showing a more promising near-term buy signal. Celgene's reward to risk is promising.
Go Long Mylan N.V. After Earnings With Confidence
Biotech companies are still under threat from the White House. So I sell risk in Mylan for income into those fears. Bet on MYL stock support for cash.
Buy Allergan Plc Ordinary Shares After the Earnings!
After a long stint of selling, AGN stock is finally showing signs of stabilization. I want to generate income from Allergan support.
Pfizer Inc. Stock Is Boring, and That’s Perfect
Pfizer has been a boring stock for years. Which makes PFE stock perfect to sell downside risk against unlikely scenarios.
Buy the Dip in Amgen, Inc. While Wall Street Fears It
Biotech falling knives like Amgen are notoriously dangerous, but AMGN stock has value against which I am willing to bet bullish.
Trade of the Day: Amgen, Inc. Nears a Buy Point Again
This latest pullback in AMGN stock now looks to provide a better reward-to-risk opportunity to buy Amgen again.
Catch This Falling Knife — Go Long Celgene Corporation
Pharma stock falling knives are the scariest to catch. But this reaction to the Celgene headline is overdone. Catch CELG but with caution.
Going Long Pfizer Inc. (PFE) Stock Is an Easy Pill to Swallow
Momentum rallies are often a show of good support. Bet on Pfizer (PFE ) stock's proven levels to hold for at least six months.
Gilead Sciences, Inc. (GILD) Stock Got Its Mojo Back
For a while GILD stock was a hideous knife to catch. But now that it reestablished its bottom, I can safely make money in Gilead.
Trade of the Day: Amgen, Inc. (AMGN) Stock Has Plenty More Upside
AMGN stock is higher by just about 27% for the year-to-date, but in the bigger picture Amgen really just started on a new breakout rally.
Buy Allergan plc Ordinary Shares (AGN) Stock and Don’t Look Back!
Pharma stocks like Allergan scare most investors out of trading them when they fall. Sell AGN puts with a big buffer for easy profits.
Profit From the Biogen Inc (BIIB) Stock Dip!
Momentum stocks especially in the biotech industry are daunting knives to catch. Make it easier by selling puts for income with a big buffer.
